Complete Revascularization, Protected PCI

Clinical Relevance of Revascularization Extent in Protected PCI: Insight From Italian Studies

 

Francesco Burzotta, MD, discusses the clinical impact of revascularization extent in Protected PCI. Notably, he highlights results from the large Revascularization Extent in Impella® Italian Registry (R-IMP-IT) which include:

  • More extensive revascularization achieved during Impella Protected PCI (revascularization index (RI) ≥0.67) is associated with significant reduction in the primary endpoint (all cause death, nonfatal MI, and nonfatal stroke at 1-year follow-up) for the entire study population as well as in the high-risk PCI subgroup of patients
  • Significant reduction in the secondary endpoint of all cause death in the more extensive revascularization group for the entire study population
  • Better clinical outcomes in both cardiogenic shock and high-risk PCI subgroups with more complete revascularization
  • Operators performing Impella-Protected PCI may aim to improve late clinical outcomes by achieving more extensive revascularization
  • Because better outcomes were associated with an RI ≥0.67, operators can use their clinical judgment in determining which lesions to treat since not all lesions need to be treated to achieve the clinical advantages

 

 

View more resources

IMP-1756

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].